179 related articles for article (PubMed ID: 10181723)
1. Revisions to the general safety test requirements for biological products--FDA. Direct final rule: confirmation in part and withdrawal in part.
Fed Regist; 1998 Aug; 63(150):41718. PubMed ID: 10181723
[TBL] [Abstract][Full Text] [Related]
2. Revisions to the general safety requirements for biological products--FD. Direct final rule.
Fed Regist; 1998 Apr; 63(75):19399-403. PubMed ID: 10178869
[TBL] [Abstract][Full Text] [Related]
3. Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(75):19431-4. PubMed ID: 10178870
[TBL] [Abstract][Full Text] [Related]
4. Revisions to the requirements applicable to blood, blood components, and source plasma; confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment.
Fed Regist; 2001 Jan; 66(7):1834-7. PubMed ID: 11503754
[TBL] [Abstract][Full Text] [Related]
5. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(170):46718. PubMed ID: 10182705
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Jul; 63(147):40825. PubMed ID: 10181716
[TBL] [Abstract][Full Text] [Related]
8. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment.
Fed Regist; 2000 Mar; 65(50):13678-9. PubMed ID: 11010647
[TBL] [Abstract][Full Text] [Related]
9. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
[TBL] [Abstract][Full Text] [Related]
10. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
[TBL] [Abstract][Full Text] [Related]
11. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(166):45716-7. PubMed ID: 10182694
[TBL] [Abstract][Full Text] [Related]
12. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
[TBL] [Abstract][Full Text] [Related]
13. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
[TBL] [Abstract][Full Text] [Related]
14. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
[TBL] [Abstract][Full Text] [Related]
15. Administrative practices and procedures; internal agency review of decisions--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Sep; 63(184):50757. PubMed ID: 10185804
[TBL] [Abstract][Full Text] [Related]
16. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; reports of corrections and removals--FDA. Direct final rule.
Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
[TBL] [Abstract][Full Text] [Related]
18. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
[TBL] [Abstract][Full Text] [Related]
19. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Dec; 63(239):68710-2. PubMed ID: 10187560
[TBL] [Abstract][Full Text] [Related]
20. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
